Oriental Aromatics Ltd Q2 FY2026 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/sbhgwpk6zl16ojsiira0f7s6.pdf

Key Takeaways


The Conscious Margin Trade-Off

Parag Satoskar: "It was a conscious decision to hold for, ensure that our market share in every business that we currently have stays."

Mahad: The Ramp-Up Drag


Chinese Competition & Pricing Pressure

Parag Satoskar: "I would not say dumping, but they are very effectively selling those materials in the non-tariff markets like Southeast Asia, India, which is a large consumer of aroma ingredients and EU."

Camphor: A Structural Oversupply


Demand Visibility & Growth Drivers


Balance Sheet & Cash Flow

Parag Satoskar: "We also have taken some strategic decisions on the fragrance raw materials where we feel that the prices are at their lowest and would only go up from here."

Guidance & Commitments

CommitmentSpecificsTimeline
Mahad EBITDA breakevenPlant to become EBITDA positiveComing couple of quarters
Mahad margin drag normalization1.5–2% point drag to fadeNext few quarters
Group margin restorationReturn to target range of 8–10%Unspecified; linked to Mahad stabilization and CPR benefits
CPR cost-reduction benefitsProcess and batch-time improvements to lift margins even at current pricesComing quarters
Anti-dumping actionEvaluate situation; take necessary steps if need arisesNo timeline; currently not pursuing

Key Metrics

MetricQ2 FY26
Operating revenue₹271 cr, +15% YoY
Operating revenue growth QoQ20% over Q1 FY26
EBITDA₹17 cr, vs ₹29 cr in Q2 FY25
EBITDA margin6.34%, vs 8% in Q1 FY26
Net profit₹0.74 cr, vs ₹14.78 cr in Q2 FY25
PAT margin0.26%
H1 FY26 operating revenue₹497 cr, +10% YoY
H1 FY26 EBITDA₹35 cr, vs ₹51 cr in H1 FY25
H1 FY26 EBITDA margin7.11%, vs 11.20% in H1 FY25
H1 FY26 net profit₹1.24 cr, vs ₹25.75 cr in H1 FY25
Net debt-to-equity0.60x as of 30 Sep 2025
Production growth+26% QoQ and +10% YoY
Sales volume growth+30% QoQ and +21% YoY
Mahad plant capacity utilization~20–21% in the last one to two quarters, phase 1 capacity 250 MT annually
Baroda facility utilization (ex-hydrogenation)90–95%
Hydrogenation plant utilization (Baroda)65–70%
Bareilly plant utilization85–90%
Ambernath fragrance division utilization100% in one shift, expandable to 3x
Mahad plant EBITDA drag1.5% to 2% point drag on Group EBITDA
Implied selling price reduction~6% (per an analyst's math, management confirmed broadly right)